Sequential mavacamten therapy and TAVRtavr in an elderly patient with concomitant severe aortic stenosis and obstructive hypertrophic cardiomyopathy

30 August 2026 (17:36 - 17:48)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Yihang Wu

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)

4 More presentations in this session

Presentation thumbnail

Transcatheter aortic valve implantation under extracorporeal membrane oxygenation in a patient with cardiogenic shock due to a degenerated bioprosthesis

Doctor M. Rodrigues (Rio de Janeiro, BR)

Presentation thumbnail

Mid-term outcomes after staged transcatheter management of severe native aortic regurgitation and cardiac resynchronisation therapy in a high-risk patient

Doctor T. Camuz (Istanbul, TR)

Presentation thumbnail

Navigating the perfect storm: Cardiac Arrest, AMA, and redo TAVI.

Doctor R. Alotaibi (Riyadh, SA)

Presentation thumbnail

Between a rock and a hard place

Doctor R. Murray (Kuala Lumpur, MY)

Access the full session

Session thumbnail

Transcatheter aortic valve implantation in challenging clinical scenarios

The Event

Event poster

ESC Congress 2026

30 August 2026 17:36 CET

You may be interested in

Congress Presentation

Mavacamten therapy in hypertrophic obstructive cardiomyopathy revealing severe aortic stenosis: a case highlighting diagnostic complexity

11 May 2026

Congress Presentation

Mavacamten reduces left ventricular mechanical dispersion in hypertrophic obstructive cardiomyopathy

12 December 2024

Congress Session

Taking a deeper dive in cardiomyopathies

19 May 2025

Webinar

The spectrum of management options for the left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

28 October 2020

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources